Basic Information
Elstar Therapeutics provides biotechnology research and development services aimed at generating first-class multispecific and multifunctional immunotherapies. The company's biotechnology R&D services focus on antibody development to produce molecules with pharmacological properties for the treatment of various diseases, such as oncology and autoimmune disorders, enabling patients to combat immune diseases more effectively.
Elstar Therapeutics, Inc.
--
15~50 people
January 01, 2015
--
Enterprise Profile
Concept

